HUMAW (STOCKS)
Humacyte, Inc. Warrant
$0.125300
+0.000000 (+0.00%)
Prev close: $0.125300
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Laura E. Niklason, MD, PhD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 220
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.57M |
| Nonoperating Income/Loss | $68.42M |
| Operating Expenses | $106.34M |
| Research and Development | $75.35M |
| Operating Income/Loss | -$105.39M |
| Income/Loss From Continuing Operations After Tax | -$36.97M |
| Income/Loss From Continuing Operations Before Tax | -$139.69M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$36.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$36.97M |
| Net Income/Loss Available To Common Stockholders, Basic | -$36.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.26 |
| Diluted Earnings Per Share | -$0.26 |
| Basic Average Shares | 304,701,983 |
| Diluted Average Shares | 151,369,525 |
| Assets | $91.51M |
| Current Assets | $41.35M |
| Inventory | $18.42M |
| Other Current Assets | $22.93M |
| Noncurrent Assets | $50.16M |
| Fixed Assets | $19.86M |
| Other Non-current Assets | $30.30M |
| Liabilities | $96.26M |
| Current Liabilities | $25.58M |
| Accounts Payable | $9.58M |
| Wages | $6.19M |
| Other Current Liabilities | $9.81M |
| Noncurrent Liabilities | $70.68M |
| Equity | -$4.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$4.75M |
| Liabilities And Equity | $91.51M |
| Net Cash Flow From Operating Activities | -$105.50M |
| Net Cash Flow From Operating Activities, Continuing | -$105.50M |
| Net Cash Flow From Investing Activities | -$908.00K |
| Net Cash Flow From Investing Activities, Continuing | -$908.00K |
| Net Cash Flow From Financing Activities | $55.32M |
| Net Cash Flow From Financing Activities, Continuing | $55.32M |
| Net Cash Flow | -$51.08M |
| Net Cash Flow, Continuing | -$51.08M |
| Comprehensive Income/Loss | -$36.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$36.97M |
| Other Comprehensive Income/Loss | -$36.97M |